Del Mar Integrative Medicine - Medicare Primary Care in Del Mar, CA

Del Mar Integrative Medicine is a medicare enrolled primary clinic (General Practice) in Del Mar, California. The current practice location for Del Mar Integrative Medicine is 1349 Camino Del Mar Ste B, Del Mar, California. For appointments, you can reach them via phone at (858) 925-8233. The mailing address for Del Mar Integrative Medicine is 1349 Camino Del Mar Ste B, Del Mar, California and phone number is (858) 925-8233.

Del Mar Integrative Medicine is licensed to practice in California (license number 20A4242). The clinic also participates in the medicare program and its NPI number is 1043722788. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (858) 925-8233.

Contact Information

Del Mar Integrative Medicine
1349 Camino Del Mar Ste B
Del Mar
CA 92014-2553
(858) 925-8233
(858) 925-8218

Primary Care Clinic Profile

Full NameDel Mar Integrative Medicine
SpecialityGeneral Practice
Location1349 Camino Del Mar Ste B, Del Mar, California
Authorized Official Name and PositionArnold S Kremer (OWNER)
Authorized Official Contact8589258233
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Del Mar Integrative Medicine
1349 Camino Del Mar Ste B
Del Mar
CA 92014-2553

Ph: (858) 925-8233
Del Mar Integrative Medicine
1349 Camino Del Mar Ste B
Del Mar
CA 92014-2553

Ph: (858) 925-8233

NPI Details:

NPI Number1043722788
Provider Enumeration Date11/03/2017
Last Update Date02/13/2018

Medicare PECOS Information:

Medicare PECOS PAC ID1052678018
Medicare Enrollment IDO20171129000816

News Archive

Variations in RANBP1 gene may disrupt brain signaling in neuropsychiatric conditions

Scientists have identified a gene that appears to play a significant role in raising a person's risk of having more severe subtypes of autism that co-occur with other genetic diseases, such as the chromosomal disorder 22q11.2 deletion syndrome.

New procedure can shut down irregular heart rhythms

Researchers from UC San Diego, the University of California Los Angeles and Indiana University report having found, for the first time, that atrial fibrillation or irregular heart rhythms is caused by small electrical sources within the heart, in the form of electrical spinning tops ("rotors") or focal beats. Importantly, they found a way of detecting these key sources, then precisely targeting them for therapy that can shut them down in minutes with long lasting results.

Sen. Grassley seeks funding extension for hospitals to ensure Medicare reimbursements reflect local wages

Senate Finance Committee Chair Chuck Grassley (R-Iowa) on Friday said that during the lame-duck session of Congress he will seek a six-month extension of a provision - Section 508 of the 2003 Medicare law - that allows reclassification of certain hospitals into different geographic regions for the application of the wage index to receive higher reimbursements, CQ HealthBeat reports.

BioSante's GVAX CML Vaccine granted FDA Orphan Drug designation

BioSante Pharmaceuticals, Inc. today announced the receipt of Orphan Drug designation for GVAX CML Vaccine in the treatment of chronic myeloid leukemia (CML) from the FDA's Office of Orphan Products Development. Orphan drug designation, as granted by the U.S. Orphan Drug Act, is for a product to treat a rare disease or condition that affects fewer than 200,000 people in the U.S. Orphan drug designation qualifies the sponsor of the product for tax credits and seven years of marketing exclusivity, among other benefits.

Hikma prepares to launch colchicine 0.6mg capsules in the US market

Hikma Pharmaceuticals PLC, the fast growing multinational pharmaceutical group, today notes that Takeda Pharmaceuticals U.S.A. Inc. has been unsuccessful in appealing the decision by the United States District Court for the District of Delaware to deny Takeda's motion for a preliminary injunction in relation to the distribution of Hikma's colchicine 0.6mg capsules for the prophylaxis of gout flares in adults.

Read more Medical News

› Verified 3 days ago

Medical Identifiers

Medical identifiers for Del Mar Integrative Medicine such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1043722788NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208D00000XGeneral Practice 20A4242 (California)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Del Mar Integrative Medicine acts as a billing entity for following providers:
Provider NameArnold S Kremer
Provider TypePractitioner - Emergency Medicine
Provider IdentifiersNPI Number: 1104846344
PECOS PAC ID: 7810882370
Enrollment ID: I20040216000538

News Archive

Variations in RANBP1 gene may disrupt brain signaling in neuropsychiatric conditions

Scientists have identified a gene that appears to play a significant role in raising a person's risk of having more severe subtypes of autism that co-occur with other genetic diseases, such as the chromosomal disorder 22q11.2 deletion syndrome.

New procedure can shut down irregular heart rhythms

Researchers from UC San Diego, the University of California Los Angeles and Indiana University report having found, for the first time, that atrial fibrillation or irregular heart rhythms is caused by small electrical sources within the heart, in the form of electrical spinning tops ("rotors") or focal beats. Importantly, they found a way of detecting these key sources, then precisely targeting them for therapy that can shut them down in minutes with long lasting results.

Sen. Grassley seeks funding extension for hospitals to ensure Medicare reimbursements reflect local wages

Senate Finance Committee Chair Chuck Grassley (R-Iowa) on Friday said that during the lame-duck session of Congress he will seek a six-month extension of a provision - Section 508 of the 2003 Medicare law - that allows reclassification of certain hospitals into different geographic regions for the application of the wage index to receive higher reimbursements, CQ HealthBeat reports.

BioSante's GVAX CML Vaccine granted FDA Orphan Drug designation

BioSante Pharmaceuticals, Inc. today announced the receipt of Orphan Drug designation for GVAX CML Vaccine in the treatment of chronic myeloid leukemia (CML) from the FDA's Office of Orphan Products Development. Orphan drug designation, as granted by the U.S. Orphan Drug Act, is for a product to treat a rare disease or condition that affects fewer than 200,000 people in the U.S. Orphan drug designation qualifies the sponsor of the product for tax credits and seven years of marketing exclusivity, among other benefits.

Hikma prepares to launch colchicine 0.6mg capsules in the US market

Hikma Pharmaceuticals PLC, the fast growing multinational pharmaceutical group, today notes that Takeda Pharmaceuticals U.S.A. Inc. has been unsuccessful in appealing the decision by the United States District Court for the District of Delaware to deny Takeda's motion for a preliminary injunction in relation to the distribution of Hikma's colchicine 0.6mg capsules for the prophylaxis of gout flares in adults.

Read more Medical News

› Verified 3 days ago

News Archive

Variations in RANBP1 gene may disrupt brain signaling in neuropsychiatric conditions

Scientists have identified a gene that appears to play a significant role in raising a person's risk of having more severe subtypes of autism that co-occur with other genetic diseases, such as the chromosomal disorder 22q11.2 deletion syndrome.

New procedure can shut down irregular heart rhythms

Researchers from UC San Diego, the University of California Los Angeles and Indiana University report having found, for the first time, that atrial fibrillation or irregular heart rhythms is caused by small electrical sources within the heart, in the form of electrical spinning tops ("rotors") or focal beats. Importantly, they found a way of detecting these key sources, then precisely targeting them for therapy that can shut them down in minutes with long lasting results.

Sen. Grassley seeks funding extension for hospitals to ensure Medicare reimbursements reflect local wages

Senate Finance Committee Chair Chuck Grassley (R-Iowa) on Friday said that during the lame-duck session of Congress he will seek a six-month extension of a provision - Section 508 of the 2003 Medicare law - that allows reclassification of certain hospitals into different geographic regions for the application of the wage index to receive higher reimbursements, CQ HealthBeat reports.

BioSante's GVAX CML Vaccine granted FDA Orphan Drug designation

BioSante Pharmaceuticals, Inc. today announced the receipt of Orphan Drug designation for GVAX CML Vaccine in the treatment of chronic myeloid leukemia (CML) from the FDA's Office of Orphan Products Development. Orphan drug designation, as granted by the U.S. Orphan Drug Act, is for a product to treat a rare disease or condition that affects fewer than 200,000 people in the U.S. Orphan drug designation qualifies the sponsor of the product for tax credits and seven years of marketing exclusivity, among other benefits.

Hikma prepares to launch colchicine 0.6mg capsules in the US market

Hikma Pharmaceuticals PLC, the fast growing multinational pharmaceutical group, today notes that Takeda Pharmaceuticals U.S.A. Inc. has been unsuccessful in appealing the decision by the United States District Court for the District of Delaware to deny Takeda's motion for a preliminary injunction in relation to the distribution of Hikma's colchicine 0.6mg capsules for the prophylaxis of gout flares in adults.

Read more News

› Verified 3 days ago


General Practice in Del Mar, CA

Jennifer Tran Do, Inc.
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 445 Marine View Ave Ste 300, Del Mar, CA 92014
Phone: 858-740-7087    Fax: 858-997-2591
Michael Markopoulos Md Inc
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 2683 Via De La Valle, Suite G626, Del Mar, CA 92014
Phone: 858-481-0412    
Paul J Haydu Md A Medical Corporation
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1561 San Dieguito Dr, Del Mar, CA 92014
Phone: 858-481-0145    
Del Mar Integrative Medicne
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1349 Camino Del Mar, Suite B, Del Mar, CA 92014
Phone: 858-755-0084    Fax: 858-712-4587
Cameron S Francis Md Inc
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1431 Camino Del Mar, Del Mar, CA 92014
Phone: 858-450-1555    Fax: 858-450-1527
Larson Medical Group, Inc
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1442 Camino Del Mar Ste 212, Del Mar, CA 92014
Phone: 760-634-1704    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.